Regulatory News Service (RNS)

View all

Results, Reports and Presentations

• Q2 2024 Results In Line with Updated Guidance; $100m Share Buyback Announced

  July 25 2024 Download (637KB)

• 2024 Jefferies Global Healthcare Conference

  June 5 2024 Download (905KB)

• Analyst Teach-in

  May 23 2024 Download (4.82MB)

• Q1 2024 Financial Results

  April 25 2024 Download (529KB)

• Annual Report and Accounts 2023

  March 13 2024 Download (15.6MB)

View all

Latest News

• Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion

  October 10 2024

• Indivior's SUBLOCADE® Rapid Induction/Alternative Injection Site Prior Approval Supplement (PAS) Receives FDA Priority Review

  October 7 2024

• Indivior Provides Update on Aelis Farma's Clinical Phase 2B Study Results with AEF0117 in Participants with Cannabis Use Disorder

  September 4 2024

• Indivior Announces BARDA's First Order of OPVEE® to Combat Opioids and Aid in National Preparedness

  August 26 2024

• Indivior Announces Q2 2024 Financial Results

  July 25 2024

View all